Recently, a medical research team led by Peter S. Finamore evaluated the safety of transvaginal mesh, a type of synthetic tissue inserted through the vagina used to repair damaged areas of tissue in pelvic organ prolapsed (POP) and other ailments.  Reviewing a set of 124 patients who had undergone “mesh-augmented vaginal reconstructive surgery during an 18-month period,”[1] the Finamore et al. (2009) team found an overall rate of vaginal mesh erosion of 11.3%.

Vaginal mesh erosion is defined for the purposed of this report as “any exposure of mesh upon visual inspection of the entire vagina at the 3-month postoperative visit.”[2]

This research was undertaken due to a growing conversation in the medical community regarding the safety of transvaginal mesh.  Recently, over 1000 adverse events have been reported to the United States Food and Drug Administration in connection with use of transvaginal mesh, and medical researchers have found complications such as “infection, seroma formation, biomaterial-related intestinal obstruction, fistula formation, and shrinkage of the mesh,”[3] to occur not infrequently.

Due to the fact that the manufacturers of transvaginal mesh products have failed to notify users of the dangers associated with the use of their product, the safety of 56 transvaginal mesh products have not become under review, and a number of transvaginal mesh lawsuits are currently being filed.  If you or a loved one used transvaginal mesh and experienced vaginal mesh erosion or another transvaginal mesh adverse health event, please do not hesitate to contact our team of transvaginal mesh lawyers.

At your convenience, you may reach our offices by phone at (855) 452-5529 or by e-mail at  We have the experience, resources, and skills required to win the justice you deserve.  Call today to see how we can help.

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have additional questions about Transvaginal Mesh.

[1] Finamore, PS et al “Risk factors for mesh erosion 3 months following vaginal reconstructive surgery using commercial kits vs. fashioned mesh-augmented vaginal repairs” Int Urogynecol J (2010) 21:285-91

[2] Ibid.

[3] Ibid.